AlphAIalphai — Financial news for AI agents
theglobeandmail.comJUN 56 min read$ORCLNeutralMed

Wall Street’s week ahead: Blockbuster SpaceX IPO set to test high-flying U.S. stocks rally

Wall Street heads into next week with SpaceX’s long-awaited IPO expected after pricing on June 11 and Nasdaq trading on June 12. The deal targets $75 billion and a $1.75 trillion valuation, following a 2025 net loss of $4.94 billion and 33% revenue growth to $18.67 billion. Markets also watch CPI/PPI data and tech earnings (Oracle, Adobe) after Friday’s jobs-driven pullback.

AI DeskJune 5, 2026
Source · theglobeandmail.com
AI analysis
Actionability
Med
Sentiment · $ORCL
Neutral
Timing
Ahead of next week’s CPI/PPI prints and scheduled tech earnings (Oracle, Adobe) plus SpaceX IPO pricing/trading.
Market alignment
Supports a cautious stance: jobs-driven hawkish repricing and post-rally froth concerns.
Why this matters for $ORCL

ORCL earnings become a catalyst for the broader software/AI value-chain narrative amid rate and CPI uncertainty.

Relevance context

Oracle is named as one of the tech companies scheduled to report quarterly results next week, which the article says will test the software rebound.

Price-impact prediction

Moderate event-driven volatility; direction depends on guidance and any commentary on AI disruption and demand.

Background

The article previews a week dominated by (1) SpaceX’s massive IPO pricing/trading, (2) CPI/PPI data after strong jobs raised hawkish Fed fears, and (3) tech earnings including Oracle and Adobe.

Why it matters

The core trade tension is whether hawkish rate repricing and geopolitical/energy risks outweigh continued momentum in tech/AI. The SpaceX IPO is positioned as a sentiment benchmark that could either absorb risk appetite or expose froth.

Market relevance

Next week’s macro prints and tech earnings are framed as the main catalysts for whether the AI/tech-led rally can extend or whether a pullback emerges amid rate and energy/geopolitical risks.

Market effects

Sector

Rates sensitivity and post-rally positioning are framed as key swing factors for semis and the AI/software complex; IPO risk appetite may amplify volatility.

Regional

Primarily U.S.-centric via Fed expectations, Nasdaq IPO trading, and S&P 500/tech leadership dynamics.

Global

Energy-price pass-through risk (oil/gas → CPI) and geopolitical escalation risk are flagged as potential global risk drivers affecting U.S. equities.

Alternative perspectives

Contrarian view

If CPI/PPI and tech earnings confirm disinflation and resilient demand, the ‘pause/pullback’ narrative could fade quickly, turning the week into a buy-the-dip setup.

Overlooked factors

SpaceX IPO mechanics (pricing June 11; trading next day) can create liquidity/positioning effects in Nasdaq/AI proxies that are not captured by macro-only rate models.

Key entities

  • company
    SpaceX

    Long-awaited IPO expected next week; pricing June 11 and trading on Nasdaq the following day.

  • company
    Oracle

    Quarterly report scheduled next week; cited as part of the tech earnings focus.

  • company
    Adobe

    Quarterly report scheduled next week; cited with a large YTD drawdown as a software read-through.

Read at source← All news

Related articles

JUN 5
$AVGOMed

Markets News, June 4, 2026: Dow Soars 875 Points to Record Close; S&P 500 Overcomes Broadcom-Led Tech Pullback; Oil Retreats

U.S. stocks finished mostly higher on June 4, with the Dow up 875 points (1.7%) to record highs, led by UnitedHealth, Goldman Sachs and Merck. The S&P 500 rose 0.4% after a nine-session win streak; the Nasdaq fell 0.1%. Broadcom and CrowdStrike dropped about 13% and 4% after results. Oil fell after Israel and Lebanon renewed a ceasefire; WTI fell ~3% to $93.20.

finance.yahoo.com10 min
JUN 5
$ORCLMed

Why Did Oracle Stock Drop Today?

Oracle (ORCL) shares fell 8.7% by 1 p.m. ET Friday, down 10.43% to $211.70, amid broad tech weakness after Broadcom’s earnings. Broadcom reported beats and forecast 89% Q3 sales growth, but its AI-chip sales outlook implied only triple growth. Guggenheim analyst John DiFucci reiterated a buy and $400 target, citing funding capacity for data-center build-out.

fool.com6 min
JUN 5
$ARMMed

Stocks sink as interest rate hike worries rattle tech amid nonstop AI spending

U.S. stocks fell Friday after a strong jobs report increased expectations for Federal Reserve rate hikes, pressuring tech and AI-related shares. The Nasdaq 100 dropped more than 3%; chipmakers and AI data-center names like Micron and Western Digital fell over 7%. The S&P 500 fell 1.8% and the Dow lost 450 points as bond yields rose. Nvidia, Oracle and IBM also declined.

nbcnews.com4 min
JUN 5
$DDOGMed

Stocks Retreat as US-Iran Peace Hopes in Doubt

US stocks retreated as markets scaled back hopes for US-Iran peace. US MBA mortgage applications fell 2.5% (purchase -2.9%, refi -2.3%); the 30-year fixed rate dropped 8 bp to 6.57%. The Fed Beige Book was hawkish, citing slight-to-moderate growth and higher inflation; John Williams said no rate change is needed. Traders priced a 3% chance of a 25 bp hike.

finance.yahoo.com7 min
JUN 4
$TEAMMed

Stocks Pressured as Middle East Flare-Ups Boost Crude Oil

Overseas markets were mixed: Euro Stoxx 50 fell 0.63%, China’s Shanghai Composite rose 0.22%, and Japan’s Nikkei hit a record up 2.50%. US 10-year yields rose to 4.489% after US-Iran tensions pushed WTI up 1% and May ADP employment surprised higher. Stocks: software and private credit slid; chipmakers gained.

finance.yahoo.com7 min
JUN 4
$ORCLMed

Oracle (NYSE:ORCL) Trading Up 2.7% – Still a Buy?

Oracle shares rose 2.7% to $236.51 on Thursday after closing at $230.33; the stock traded as high as $238.95. Midday volume was 19.25M shares, down 29% from average. Ahead of its June 10 earnings, UBS raised its ORCL target to $285. Analysts’ consensus target is $263.89.

tickerreport.com4 min